Preparation and evaluation of Lu-(177) phytate Complex for Radiosynovectomy
- PMID: 25191108
- PMCID: PMC4149764
- DOI: 10.4103/1450-1147.138570
Preparation and evaluation of Lu-(177) phytate Complex for Radiosynovectomy
Retraction in
-
Retraction: Preparation and Evaluation of Lu-177 Phytate Complex for Radiosynovectomy.World J Nucl Med. 2016 Jan-Apr;15(1):76. doi: 10.4103/1450-1147.172143. World J Nucl Med. 2016. PMID: 26912989 Free PMC article.
Abstract
Lu-(177) of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu2O3 sample with thermal neutron flux of 4 × 10(13) n/cm/s. The product was converted into chloride form which was further used for labeling of Lu(-177) phytate complex successfully with high radiochemical purity (>99.9%, instant thin layer chromatography, MeOH: H2O: Acetic acid, 4:4:2, as mobile phase). The complex stability and viscosity were checked in the final solution up to 7 days. The prepared complex solution (100 μCi/100 μl) was injected intra-articularly to the male rat knee joint. Leakage of radioactivity from the injection site and its distribution in organs were investigated up to 7 days. Approximately, all injected dose has remained in injection site 7 days after injection. The complex was proved to be a feasible agent for cavital radiotherapy in oncology and rheumatology.
Keywords: Biodistribution; lutetium-177; phytate; radiosynovectomy.
Conflict of interest statement
Figures










Similar articles
-
Development of (177)Lu-phytate Complex for Radiosynovectomy.Iran J Basic Med Sci. 2013 May;16(5):705-9. Iran J Basic Med Sci. 2013. PMID: 23826493 Free PMC article.
-
Development of (166)Ho-phytate Complex for Radiosynovectomy.Nucl Med Mol Imaging. 2011 Jun;45(2):87-92. doi: 10.1007/s13139-010-0048-6. Epub 2011 Feb 17. Nucl Med Mol Imaging. 2011. PMID: 24899986 Free PMC article.
-
Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.Nucl Med Commun. 2014 Jan;35(1):99-107. doi: 10.1097/MNM.0000000000000018. Nucl Med Commun. 2014. PMID: 24162837
-
Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.Nucl Med Biol. 2013 Oct;40(7):946-54. doi: 10.1016/j.nucmedbio.2013.05.011. Epub 2013 Jul 11. Nucl Med Biol. 2013. PMID: 23850487
-
Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176.Curr Radiopharm. 2015;8(2):95-106. doi: 10.2174/1874471008666150312160855. Curr Radiopharm. 2015. PMID: 25771378 Review.
Cited by
-
Retraction: Preparation and Evaluation of Lu-177 Phytate Complex for Radiosynovectomy.World J Nucl Med. 2016 Jan-Apr;15(1):76. doi: 10.4103/1450-1147.172143. World J Nucl Med. 2016. PMID: 26912989 Free PMC article.
References
-
- European Association of Nuclear Medicine (EANM) Procedure Guidelines for Radiosynovectomy. Guidelines issued date: 2002 Oct 4. Available at http://www.snm.org.tw/Guideline/gl_radio_synovectomy.pdf .
-
- Kropácek M, Melichar F, Henková K, Konopková M. Preparation of holmium-166 labelled macroaggregates for radionuclide synovectomy. Nucl Med Rev Cent East Eur. 2003;6:1–4. - PubMed
-
- Suzuki YS, Momose Y, Higashi N, Shigematsu A, Park KB, Kim YM, et al. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. J Nucl Med. 1998;39:2161–6. - PubMed
-
- Bodei L, Ferone D, Grana CM, Cremonesi M, Signore A, Dierckx RA, et al. Peptide receptor therapies in neuroendocrine tumors. J Endocrinol Invest. 2009;32:360–9. - PubMed
-
- Michel RB, Andrews PM, Rosario AV, Goldenberg DM, Mattes MJ. Lu- 177-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo. Nucl Med Biol. 2005;32:269–78. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous